{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstAnswered.=2017-02-09T17%3A38%3A01.277Z&tablingMemberConstituency=Witney&max-date=2018-01-25&max-answer.questionFirstAnswered.=2018-10-31T13%3A22%3A07.7Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-answer.questionFirstAnswered.=2017-02-09T17%3A38%3A01.277Z&tablingMemberConstituency=Witney&max-date=2018-01-25&max-answer.questionFirstAnswered.=2018-10-31T13%3A22%3A07.7Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstAnswered.=2017-02-09T17%3A38%3A01.277Z&tablingMemberConstituency=Witney&max-date=2018-01-25&_metadata=all&max-answer.questionFirstAnswered.=2018-10-31T13%3A22%3A07.7Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-answer.questionFirstAnswered.=2017-02-09T17%3A38%3A01.277Z&tablingMemberConstituency=Witney&max-date=2018-01-25&max-answer.questionFirstAnswered.=2018-10-31T13%3A22%3A07.7Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstAnswered.=2017-02-09T17%3A38%3A01.277Z&tablingMemberConstituency=Witney&max-date=2018-01-25&max-answer.questionFirstAnswered.=2018-10-31T13%3A22%3A07.7Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstAnswered.=2017-02-09T17%3A38%3A01.277Z&tablingMemberConstituency=Witney&max-date=2018-01-25&max-answer.questionFirstAnswered.=2018-10-31T13%3A22%3A07.7Z", "items" : [{"_about" : "http://data.parliament.uk/resources/830410", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/830410/answer", "answerText" : {"_value" : "

Reports of suspected adverse drug reactions (ADRs) are collected by the Medicines and Healthcare products Regulatory Agency (MHRA) and Commission for Human Medicines (CHM) through the spontaneous reporting scheme, the Yellow Card Scheme. The MHRA continuously monitors the safety of all medicines on the market in the United Kingdom and seeks independent expert advice from the CHM on important new safety issues.<\/p>

<\/p>

The Yellow Card Scheme collects information relating to suspected adverse drug reactions, which include both serious and non-serious effects which a doctor or patient suspects may have been due to a medicine. The MHRA has received a total of 593 suspected spontaneous ADR reports in association with citalopram between 1 January 2016 and 31 December 2017. This number includes reports received directly from healthcare professionals, patients and indirectly through pharmaceutical companies which have a legal obligation to report suspected ADRs. The number of reports received directly from the National Health Service cannot be determined.<\/p>

<\/p>

The MHRA does not hold information on deterioration of health. Each ADR report contains information on an ADR at a specific point in time, rather than a deterioration of health over a period of time, and should therefore not be interpreted as a report of a deterioration of a patient's health.<\/p>

<\/p>

The inclusion of a particular ADR in a report does not necessarily mean it has been caused by the drug, only that the reporter had a suspicion it may have, or it had a close temporal relationship to the administration of the suspect drug. The fact that symptoms occur after a treatment does not necessarily mean that they have been caused by the drug itself, as underlying illnesses and other conditions may be responsible.<\/p>

<\/p>

Citalopram is an antidepressant belonging to the class of medicines known as selective serotonin reuptake inhibitors. Citalopram is an effective medicine for the treatment of depression. Information about possible side-effects associated with treatment are provided in the product information which is available to all prescribers and patients. Data is evaluated as it emerges and where necessary regulatory action is taken and communicated to healthcare professionals and the information for patients is updated.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2018-02-01", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "124977"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-02-01T16:12:40.563Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-01-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Antidepressants"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many incidents the NHS has recorded of Citalopram leading to the deterioration of a patient's health in 2016-17.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4589", "label" : {"_value" : "Biography information for Robert Courts"} } , "tablingMemberConstituency" : {"_value" : "Witney"} , "tablingMemberPrinted" : [{"_value" : "Robert Courts"} ], "uin" : "124976"} , {"_about" : "http://data.parliament.uk/resources/830411", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/830411/answer", "answerText" : {"_value" : "

Reports of suspected adverse drug reactions (ADRs) are collected by the Medicines and Healthcare products Regulatory Agency (MHRA) and Commission for Human Medicines (CHM) through the spontaneous reporting scheme, the Yellow Card Scheme. The MHRA continuously monitors the safety of all medicines on the market in the United Kingdom and seeks independent expert advice from the CHM on important new safety issues.<\/p>

<\/p>

The Yellow Card Scheme collects information relating to suspected adverse drug reactions, which include both serious and non-serious effects which a doctor or patient suspects may have been due to a medicine. The MHRA has received a total of 593 suspected spontaneous ADR reports in association with citalopram between 1 January 2016 and 31 December 2017. This number includes reports received directly from healthcare professionals, patients and indirectly through pharmaceutical companies which have a legal obligation to report suspected ADRs. The number of reports received directly from the National Health Service cannot be determined.<\/p>

<\/p>

The MHRA does not hold information on deterioration of health. Each ADR report contains information on an ADR at a specific point in time, rather than a deterioration of health over a period of time, and should therefore not be interpreted as a report of a deterioration of a patient's health.<\/p>

<\/p>

The inclusion of a particular ADR in a report does not necessarily mean it has been caused by the drug, only that the reporter had a suspicion it may have, or it had a close temporal relationship to the administration of the suspect drug. The fact that symptoms occur after a treatment does not necessarily mean that they have been caused by the drug itself, as underlying illnesses and other conditions may be responsible.<\/p>

<\/p>

Citalopram is an antidepressant belonging to the class of medicines known as selective serotonin reuptake inhibitors. Citalopram is an effective medicine for the treatment of depression. Information about possible side-effects associated with treatment are provided in the product information which is available to all prescribers and patients. Data is evaluated as it emerges and where necessary regulatory action is taken and communicated to healthcare professionals and the information for patients is updated.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2018-02-01", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "124976"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-02-01T16:12:40.627Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-01-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Antidepressants: Side Effects"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment has been made of the side-effects of Citalopram on patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4589", "label" : {"_value" : "Biography information for Robert Courts"} } , "tablingMemberConstituency" : {"_value" : "Witney"} , "tablingMemberPrinted" : [{"_value" : "Robert Courts"} ], "uin" : "124977"} , {"_about" : "http://data.parliament.uk/resources/822976", "AnsweringBody" : [{"_value" : "Foreign and Commonwealth Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/822976/answer", "answerText" : {"_value" : "

The UK has some concerns over freedom of religious belief in Turkey and the issue continues to be a priority area for our bilateral projects in Turkey. We have raised our concerns with Turkish interlocutors up to and including at Prime Ministerial level. We will continue to encourage Turkey to work towards the full protection of fundamental rights, especially in the areas of minority rights, freedom of religion and freedom of expression.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/343", "label" : {"_value" : "Biography information for Sir Alan Duncan"} } , "answeringMemberConstituency" : {"_value" : "Rutland and Melton"} , "answeringMemberPrinted" : {"_value" : "Sir Alan Duncan"} , "dateOfAnswer" : {"_value" : "2018-01-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-01-23T17:20:49.903Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "16"} , "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"} , "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"} , "date" : {"_value" : "2018-01-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Turkey: Religious Freedom"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Foreign and Commonwealth Affairs, what recent assessment he has made of the level of religious freedom in Turkey; and what steps the Government is taking to promote and protect the right to freedom of religion or belief in that country.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4589", "label" : {"_value" : "Biography information for Robert Courts"} } , "tablingMemberConstituency" : {"_value" : "Witney"} , "tablingMemberPrinted" : [{"_value" : "Robert Courts"} ], "uin" : "122659"} , {"_about" : "http://data.parliament.uk/resources/818016", "AnsweringBody" : [{"_value" : "Home Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/818016/answer", "answerText" : {"_value" : "

The Government set up the Joint Fraud Taskforce through which police, banks and trading standards work together to help protect vulnerable people from the fraudulent approaches made by doorstep criminals. The Banking Protocol, which helps bank staff recognise signs of fraud, such as unusually high cash withdrawals, has stopped over £9 million pounds from getting into criminal hands and led to over 100 arrests.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1539", "label" : {"_value" : "Biography information for Mr Ben Wallace"} } , "answeringMemberConstituency" : {"_value" : "Wyre and Preston North"} , "answeringMemberPrinted" : {"_value" : "Mr Ben Wallace"} , "dateOfAnswer" : {"_value" : "2018-01-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-01-08T16:50:10.16Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "1"} , "answeringDeptShortName" : {"_value" : "Home Office"} , "answeringDeptSortName" : {"_value" : "Home Office"} , "date" : {"_value" : "2018-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Direct Selling"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "What steps she is taking to tackle doorstep crime.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4589", "label" : {"_value" : "Biography information for Robert Courts"} } , "tablingMemberConstituency" : {"_value" : "Witney"} , "tablingMemberPrinted" : [{"_value" : "Robert Courts"} ], "uin" : "903120"} , {"_about" : "http://data.parliament.uk/resources/806189", "AnsweringBody" : [{"_value" : "Foreign and Commonwealth Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/806189/answer", "answerText" : {"_value" : "

The oceans are vital to support life on earth, and are critical to the United Kingdom. The UK and its Overseas Territories are custodians to the fifth-largest marine estate in the world. The Foreign and Commonwealth Office (FCO) therefore has an important role in promoting security at sea and improving the conservation and sustainable use of our oceans, and we are looking at how the UK can take this yet further. We already take a leading role on maritime protection and are on track to deliver marine protected areas across nearly 4 million square kilometres of the planet's oceans and seas through our Blue Belt programme by 2020.<\/p>

The FCO works closely with the Department for Environment Food & Rural Affairs (DEFRA) and others including agencies such as the UK Hydrographic Office, the Centre for Environment Fisheries and Aquaculture Science and the Maritime and Coastguard Agency to promote global marine conservation. The FCO and DEFRA in particular have also been closely involved in the negotiations of the Preparatory Committee (PrepCom) to develop an international legally binding instrument under the United Nations Convention on the Law of the Sea on the conservation and sustainable use of marine biological diversity of areas beyond national jurisdiction.<\/p>

I am committed to combatting the menace of marine plastic pollution. This Government introduced a charge on plastic carrier bags, cutting their use in the UK by 80 per cent, and avoiding the disposal of 9 billion carrier bags, many of which might otherwise have ended up in the oceans. And from 1 January 2018, we will ban the production of plastic microbeads, the strongest legal measure of its kind anywhere in the world.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/343", "label" : {"_value" : "Biography information for Sir Alan Duncan"} } , "answeringMemberConstituency" : {"_value" : "Rutland and Melton"} , "answeringMemberPrinted" : {"_value" : "Sir Alan Duncan"} , "dateOfAnswer" : {"_value" : "2017-12-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-12-21T17:27:32.703Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "16"} , "answeringDeptShortName" : {"_value" : "Foreign and Commonwealth Office"} , "answeringDeptSortName" : {"_value" : "Foreign and Commonwealth Office"} , "date" : {"_value" : "2017-12-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Marine Environment: Conservation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Foreign and Commonwealth Affairs, what his policy is on the UK's role in global ocean conservation.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4589", "label" : {"_value" : "Biography information for Robert Courts"} } , "tablingMemberConstituency" : {"_value" : "Witney"} , "tablingMemberPrinted" : [{"_value" : "Robert Courts"} ], "uin" : "119390"} , {"_about" : "http://data.parliament.uk/resources/765783", "AnsweringBody" : [{"_value" : "Department for Communities and Local Government"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/765783/answer", "answerText" : {"_value" : "

The £3 billion Home Building Fund provides long and short term loan finance to build the homes this country needs.<\/p>

Of the £3 billion Home Building Fund, £1.38 billion (46 per cent) has been allocated to successful applicants. Of the £1 billion funding specifically allocated to support small and medium sized builders, custom builders and innovators, £540 million has been allocated. The amount of that fund specifically allocated to small and medium sized builders is £292 million.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4014", "label" : {"_value" : "Biography information for Sir Alok Sharma"} } , "answeringMemberConstituency" : {"_value" : "Reading West"} , "answeringMemberPrinted" : {"_value" : "Alok Sharma"} , "dateOfAnswer" : {"_value" : "2017-10-16", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-10-16T16:35:06.263Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "7"} , "answeringDeptShortName" : {"_value" : "Communities and Local Government"} , "answeringDeptSortName" : {"_value" : "Communities and Local Government"} , "date" : {"_value" : "2017-10-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Housing: Construction"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Communities and Local Government, how much of the Home Building Fund has been allocated; and what proportion of that amount has been allocated to small and medium-sized house builders.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4589", "label" : {"_value" : "Biography information for Robert Courts"} } , "tablingMemberConstituency" : {"_value" : "Witney"} , "tablingMemberPrinted" : [{"_value" : "Robert Courts"} ], "uin" : "106267"} , {"_about" : "http://data.parliament.uk/resources/686982", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/686982/answer", "answerText" : {"_value" : "

Personnel deployed on operations enjoy access to a variety of methods for contacting their friends and family, including via internet access or mail services. Therefore the cessation of the e-bluey service will not impact on the provision of secure personal correspondence for deployed personnel.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1544", "label" : {"_value" : "Biography information for Lord Lancaster of Kimbolton"} } , "answeringMemberConstituency" : {"_value" : "Milton Keynes North"} , "answeringMemberPrinted" : {"_value" : "Mark Lancaster"} , "dateOfAnswer" : {"_value" : "2017-02-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-02-21T14:30:51.937Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2017-02-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Armed Forces: Communication"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Defence, what plans his Department has put in place to ensure the continuation of secure personal correspondence between armed forces personnel deployed in remote locations and their families after the e-bluey system ends on 31 March 2017.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4589", "label" : {"_value" : "Biography information for Robert Courts"} } , "tablingMemberConstituency" : {"_value" : "Witney"} , "tablingMemberPrinted" : [{"_value" : "Robert Courts"} ], "uin" : "63576"} , {"_about" : "http://data.parliament.uk/resources/683111", "AnsweringBody" : [{"_value" : "Department for International Trade"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/683111/answer", "answerText" : {"_value" : "

Great.gov.uk is designed to engage as many businesses as possible, especially small and medium-sized enterprises and to date we have had a highly positive response to our digital services with over 5000 business registered for accounts, including 1500 registrations for our \u201cFind a Buyer\u201d Service and over 360,000 visits to the site.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1526", "label" : {"_value" : "Biography information for Greg Hands"} } , "answeringMemberConstituency" : {"_value" : "Chelsea and Fulham"} , "answeringMemberPrinted" : {"_value" : "Greg Hands"} , "dateOfAnswer" : {"_value" : "2017-02-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-02-09T17:38:01.277Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "202"} , "answeringDeptShortName" : {"_value" : "International Trade"} , "answeringDeptSortName" : {"_value" : "International Trade"} , "date" : {"_value" : "2017-02-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Small Businesses: Digital Technology"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for International Trade, what assessment he has made of the level of interest among small and medium-sized enterprises in the Great.gov.uk digital platform.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4589", "label" : {"_value" : "Biography information for Robert Courts"} } , "tablingMemberConstituency" : {"_value" : "Witney"} , "tablingMemberPrinted" : [{"_value" : "Robert Courts"} ], "uin" : "62768"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 8, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }